RU95121825A -
PHARMACEUTICAL COMPOSITION THIMOCONANE AND 3'-AZIDOTHYMIDINE
- Google Patents
PHARMACEUTICAL COMPOSITION THIMOCONANE AND 3'-AZIDOTHYMIDINE
Info
Publication number
RU95121825A
RU95121825ARU95121825/14ARU95121825ARU95121825ARU 95121825 ARU95121825 ARU 95121825ARU 95121825/14 ARU95121825/14 ARU 95121825/14ARU 95121825 ARU95121825 ARU 95121825ARU 95121825 ARU95121825 ARU 95121825A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация С.п.А.filedCriticalФармация С.п.А.
Publication of RU95121825ApublicationCriticalpatent/RU95121825A/en
1. Фармацевтическая композиция для лечения ретровирусных заболеваний, содержащая фармацевтически приемлемый носитель или разбавитель и эффективное количество активного агента, характеризующаяся тем, что в качестве активного агента используется сочетание тимоктонана и антиретровирусного агента.1. A pharmaceutical composition for treating retroviral diseases, comprising a pharmaceutically acceptable carrier or diluent and an effective amount of an active agent, characterized in that a combination of thymoctonan and an antiretroviral agent is used as the active agent. 2. Фармацевтическая композиция по п. 1, где ретровирусным заболеванием является ВИЧ-инфицирование. 2. The pharmaceutical composition according to claim 1, wherein the retroviral disease is HIV infection. 3. Фармацевтическая композиция по пп. 1 и 2, где ретровирусным заболеванием является ВИЧ-1-инфицирование. 3. The pharmaceutical composition according to paragraphs. 1 and 2, where the retroviral disease is HIV-1 infection. 4. Фармацевтическая композиция по пп. 1-3, где антиретровирусным агентом является AЗT, ddl или ddС. 4. The pharmaceutical composition according to paragraphs. 1-3, where the antiretroviral agent is AZT, ddl or ddC. 5. Способ лечения ретровирусных заболеваний, включающий применение эффективного количества активного агента, отличающийся тем, что в качестве активного агента используют сочетание тимоктонана и антиретровирусного агента путем одновременного, раздельного или последовательного их применения. 5. A method of treating retroviral diseases, comprising using an effective amount of an active agent, characterized in that a combination of thymoctonan and an antiretroviral agent is used as the active agent by their simultaneous, separate or sequential use. 6. Способ лечения по п. 5, где ретровирусным заболеванием является ВИЧ-инфицирование. 6. The method of treatment according to claim 5, wherein the retroviral disease is HIV infection. 7. Способ лечения по пп. 5 и 6, где ретровирусным заболеванием является ВИЧ-1-инфицирование. 7. The method of treatment according to paragraphs. 5 and 6, where the retroviral disease is HIV-1 infection. 8. Способ лечения по пп. 5-7, где антивирусным агентом является АЗТ, ddl или ddС. 8. The method of treatment according to paragraphs. 5-7, where the antiviral agent is AZT, ddl or ddC.
RU95121825/14A1994-03-011995-02-23
PHARMACEUTICAL COMPOSITION THIMOCONANE AND 3'-AZIDOTHYMIDINE
RU95121825A
(en)
method for treating a human suffering from viral infection, pharmaceutical composition, combination of compounds for the preparation of medications and pharmaceutical combination
METHOD TO PREPARE A COMPOSITION FOR TREATMENT OF VIRAL INFECTIONS AND A METHOD TO SYNTHESIZE 3 'AZIDO 2', 3 'DIDEOXIURIDINA INTENDED FOR THE PREPARATION OF SUCH COMPOSITION.
Pharmaceutical composition comprising 3'-deoxythymidine-2'-ene (3'-deoxy-2 ', 3'-didehydrothymidine) for the treatment of retrovirus-stained patients.
Pharmaceutical composition, processes for increasing and maintaining the homogeneity of a pharmaceutical composition and for treating, reversing, reducing or inhibiting retroviral infections, use of abacavir, lamivudine, zidovudine or a pharmaceutically acceptable derivative thereof, and a pharmaceutically acceptable gliding agent , article of manufacture, and, process for the preparation of a pharmaceutical composition
Compound, use of the same and its pharmaceutically acceptable salts, and pharmaceutical composition for the treatment of viral herpes infections in patients
Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses